The Six Ds of Exponentials and drug discovery: A path toward reversing Eroom’s law

IF 7.5 2区 医学 Q1 PHARMACOLOGY & PHARMACY Drug Discovery Today Pub Date : 2025-04-01 DOI:10.1016/j.drudis.2025.104341
Alexander Tropsha , Holli-Joi Martin , Artem Cherkasov
{"title":"The Six Ds of Exponentials and drug discovery: A path toward reversing Eroom’s law","authors":"Alexander Tropsha ,&nbsp;Holli-Joi Martin ,&nbsp;Artem Cherkasov","doi":"10.1016/j.drudis.2025.104341","DOIUrl":null,"url":null,"abstract":"<div><div>Many technological sectors underwent recent exponential growth because of digital disruption, a phenomenon Peter Diamantis characterized as the ‘Six Ds of Exponentials’: digitization, deception, disruption, demonetization, dematerialization, and democratization. In contrast, drug discovery has been marked by rising costs and modest growth, if any, of annual drug approvals. We argue that the exponential growth of drug discovery can be also achieved through digital disruption brought by data expansion, mature artificial intelligence (AI), automation of experiments, public–private partnerships, and open science. We detected the emergence of all ‘Six Ds of Exponentials’ within modern drug discovery and discuss how each of the ‘Six Ds’ can further empower the field and forcefully address the societal demand for novel, potent, affordable, and accessible medicines.</div></div>","PeriodicalId":301,"journal":{"name":"Drug Discovery Today","volume":"30 4","pages":"Article 104341"},"PeriodicalIF":7.5000,"publicationDate":"2025-04-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Drug Discovery Today","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S1359644625000546","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

Many technological sectors underwent recent exponential growth because of digital disruption, a phenomenon Peter Diamantis characterized as the ‘Six Ds of Exponentials’: digitization, deception, disruption, demonetization, dematerialization, and democratization. In contrast, drug discovery has been marked by rising costs and modest growth, if any, of annual drug approvals. We argue that the exponential growth of drug discovery can be also achieved through digital disruption brought by data expansion, mature artificial intelligence (AI), automation of experiments, public–private partnerships, and open science. We detected the emergence of all ‘Six Ds of Exponentials’ within modern drug discovery and discuss how each of the ‘Six Ds’ can further empower the field and forcefully address the societal demand for novel, potent, affordable, and accessible medicines.

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
指数的六个d和药物发现:一条逆转厄鲁姆定律的道路。
由于数字化的破坏,许多技术部门经历了最近的指数增长,Peter Diamantis将这种现象描述为“指数的六个d”:数字化、欺骗、破坏、非货币化、非物质化和民主化。相比之下,药物研发的特点是成本不断上升,而年度药物批准量(如果有的话)增长缓慢。我们认为,药物发现的指数级增长也可以通过数据扩展、成熟的人工智能(AI)、实验自动化、公私合作伙伴关系和开放科学带来的数字颠覆来实现。我们发现了现代药物发现中所有“六个d指数”的出现,并讨论了每个“六个d”如何进一步增强该领域的能力,并有力地解决了社会对新颖、有效、负担得起和可获得的药物的需求。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Drug Discovery Today
Drug Discovery Today 医学-药学
CiteScore
14.80
自引率
2.70%
发文量
293
审稿时长
6 months
期刊介绍: Drug Discovery Today delivers informed and highly current reviews for the discovery community. The magazine addresses not only the rapid scientific developments in drug discovery associated technologies but also the management, commercial and regulatory issues that increasingly play a part in how R&D is planned, structured and executed. Features include comment by international experts, news and analysis of important developments, reviews of key scientific and strategic issues, overviews of recent progress in specific therapeutic areas and conference reports.
期刊最新文献
Decoding the plasma proteome: Advancing precision medicine in cardiovascular health. Contribution of revenue from drugs subject to price negotiation under the Inflation Reduction Act to the revenue, profit, and returns of pharmaceutical manufacturers. Plasmodium falciparum falcilysin as an emerging potential drug target for antimalarial drug discovery. Gallium-based antimicrobials: mechanisms of action, resistance outlook, and translational potential for next-generation anti-infective therapies. Genetic Targets, Financial Creativity: BridgeBio's Model for Sustainable Drug Development.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1